Pyrovalerone

From Wikipedia, the free encyclopedia

Pyrovalerone
Systematic (IUPAC) name
1-(4-methylphenyl)-2-(1-pyrrolidinyl)pentan-1-one
Identifiers
CAS number 3563-49-3
ATC code  ?
PubChem 14373
Chemical data
Formula C16H23NO 
Mol. mass 245.36 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status

Schedule V(US)

Routes  ?

Pyrovalerone (Centroton, Thymergix) is a stimulant drug developed in the late 1960s and used in France and some other European countries. It is sometimes prescribed for treating chronic fatigue and lethargy [1] or as an appetite suppressant, though it is used infrequently due to problems with abuse and dependence. [2] Side effects of pyrovalerone include loss of appetite, anxiety, insomnia, and tremor. Withdrawal syndrome following abuse causes depression. [3] Pyrovalerone is a Schedule V drug in the USA. [4] It is closely related to some other stimulant drugs such as prolintane and MDPV.

[edit] Identification

CAS# 1147-62-2 (pyrovalerone hydrochloride); 3563-49-3 (pyrovalerone freebase)

[edit] References

  1. ^ Gardos G, Cole JO. Evaluation of pyrovalerone in chronically fatigued volunteers. Current Therapeutic Research, Clinical and Experimental. 1971 Oct;13(10):631-5.
  2. ^ Deniker P, Loo H, Cuche H, Roux JM. Abuse of pyrovalerone by drug addicts. Annales Medico-Psychologiques (Paris) 1975 Nov;2(4):745-8.
  3. ^ http://www.biam2.org/www/Etr8623.html
  4. ^ Schedule V Controlled Substances. Retrieved on 2008-01-13.
Languages